Faqian Bu
Impact in
-
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Click Chemistry and Applications
-
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Melanoma and MAPK Pathways
- Cancer therapeutics and mechanisms
Papers in
-
- Melanoma and MAPK Pathways 5
- Histone Deacetylase Inhibitors Research 3
- Protein Degradation and Inhibitors 2
- Cancer therapeutics and mechanisms 2
-
- Synthesis and biological activity 2
- Synthesis of Tetrazole Derivatives 2
- Co-authors
- Guan Wang (12 shared papers)Liang Ouyang (11 shared papers)Shuai Wen (10 shared papers)Yiwen Zhang (3 shared papers)Aoxue Wang (4 shared papers)Junping Pei (4 shared papers)Yumeng Zhu (6 shared papers)Yuxi Wang (3 shared papers)
- Journals
- Journal of Medicinal Chemistry (5 papers)Acta Pharmaceutica Sinica B (2 papers)Angewandte Chemie International Edition (1 paper)BMJ Open (1 paper)Chemical Communications (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Faqian Bu
13 papers receiving 363 citations
Peers
Comparison fields: 5 of 77
- Organic Chemistry 115
- Molecular Biology 218
- Oncology 64
- Toxicology 8
- Biological Psychiatry 5
Countries citing papers authored by Faqian Bu
This map shows the geographic impact of Faqian Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faqian Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faqian Bu more than expected).
Fields of papers citing papers by Faqian Bu
This network shows the impact of papers produced by Faqian Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faqian Bu. The network helps show where Faqian Bu may publish in the future.
Co-authors
The 25 scholars most cited alongside Faqian Bu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 104 | |
| 2 | 2021 | 60 | |
| 3 | 2023 | 58 | |
| 4 | 2022 | 50 | |
| 5 | 2022 | 28 | |
| 6 | 2022 | 18 | |
| 7 | 2021 | 14 | |
| 8 | 2023 | 10 | |
| 9 | 2023 | 9 | |
| 10 | 2022 | 4 | |
| 11 | 2021 | 4 | |
| 12 | 2024 | 4 | |
| 13 | 2024 | 3 | |
| 14 | 2024 | 0 |
About Faqian Bu
Faqian Bu is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Epidemiology and Computational Theory and Mathematics, having authored 14 papers that have together received 366 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (5 papers), Histone Deacetylase Inhibitors Research (3 papers), Protein Degradation and Inhibitors (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Computational Drug Discovery Methods (2 papers), Cancer therapeutics and mechanisms (2 papers), Synthesis and biological activity (2 papers) and Synthesis of Tetrazole Derivatives (2 papers). The work is most often cited by research in Organic Chemistry (115 citations), Molecular Biology (218 citations), Oncology (64 citations), Toxicology (8 citations) and Biological Psychiatry (5 citations). Faqian Bu has collaborated with scholars based in China and United States. Frequent co-authors include Guan Wang, Liang Ouyang, Shuai Wen, Yiwen Zhang, Aoxue Wang, Junping Pei, Yumeng Zhu, Yuxi Wang, Xiaoli Pan and Sicheng Zhang. Their work appears in journals such as Journal of Medicinal Chemistry, Acta Pharmaceutica Sinica B, Angewandte Chemie International Edition, BMJ Open and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.